Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin Brain Stimulation and Imaging in Healthy Volunteers
NCT06835699Phase 1Completed
- Sponsor
- Johns Hopkins University
- Start
- Apr 2025
- Primary completion
- May 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of psilocybin, sponsored by Johns Hopkins University. Primary endpoints: Acute Change in Inhibitory EEG Component Amplitudes (N45, N100) from Baseline at 1.5 hours and Change in Mystical Experience Questionnaire at 1.5 hours. Started Apr 2025; status: completed.
02
Drugs
psilocybin
Beyond the preview
Go deeper on NCT06835699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06835699.